Ranitidine USP
Composition : Ranitidine USP 150mg & 300mg Tablet.
Indications : Ulcar is indicated for the
treatment of duodenal ulcer and benign
gastric ulcer, including that associated
with non-steroidal anti-inflammatory
agents.
Ulcar tablet is also indicated for the
treatment of post-operative ulcer,
oesophageal reflux disease and
Zollinger-Ellison Syndrome. Other
patients with chronic episodic dyspepsia,
characterised by pain (epigastric or
retrosternal) which is related to meals or
disturbs sleep but is not associated with
the preceding conditions may benefit
from Ranitidine treatment. Ulcar is
indicated for conditions where reduction
of gastric secretion and acid output is
desirable such as: the prophylaxis of
gastro-intestinal haemorrhage from
stress ulceration in seriously ill patients,
the prophylaxis of recurrent haemorrhage
in patients with bleeding peptic ulcers
and before general anaesthesia in
patients considered to be at risk of acid
aspiration (Mendelson's Syndrome),
particularly obstetric patients during
labour.
Dosage and administration : Ulcar
Tablet : The recommended oral dosage
of Ulcar for adults is 150mg tablet twice
daily. An alternate dosage of 300mg daily
at bed time can be used for patients in
whom dosing convenience is important.
Or as directed by a registered physician.
Use in pregnancy and lactation : Ranitidine has been assigned to
pregnancy category B by the FDA.
Packing :
Ulcar 150mg Tablet : 10x10's tablets in formed pack.
Ulcar 300mg Tablet : 5x10's tablets in formed pack.